What's on the horizon for the life sciences industry? Robin Johnson, PharmD, Gene Therapy Submissions Lead, inSeption Group What unique challenges do gene therapy submissions face compared to ...
An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief ...
Maintaining oral health is crucial for overall well-being, yet many individuals overlook the importance of proper dental care ...
Reforming patent litigation to mirror successful outcomes across Europe could significantly accelerate US biosimilar market ...
The biotherapeutics company said the treatment, LYT-200, is being evaluated in two ongoing clinical trials. It was previously granted orphan drug designation for the treatment of acute myeloid ...
Stocks like GTPL Hathway, Adani Total Gas, Polyplex Corporation, SRF, Equitas Small Finance Bank, Samvardhana Motherson ...
Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...
Increasing complexity, evolving consumer expectations, and tightened development timelines means that physical product ...
Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 ...
“Time-to-market is money,” says Lukas Kürten, Digital Innovation Manager at CPI. “If you’ve got a process that works, you’ve got to throw it into manufacturing, because you’ve got to milk your patent ...
Eligible children and adults with cystic fibrosis are continuing to receive ongoing treatment and be initiated onto treatment with these drugs, as clinically appropriate ... made through the full ...